Thus, high-dose liraglutide (Saxenda) was approved for the treatment of obesity by the US Food and Drug Administration, which became the most widely prescribed anti-obesity drug in 2020 (Neeland et al
i.e., weight maintenance and weight loss, in concomitance with a controlled intake of calories and improved physical activity, studies of three 68 weeks double-blind, placebo-controlled, randomized trials were conducted
Your healthcare team can review your overall response to GLP-1 therapy, assess whether dose adjustment might be appropriate, or consider whether the benefits of continuing treatment outweigh the impact on quality of life
M is very thoughtful about her approach in providing women confidence in their bodies again
To determine if Semaglutide GLP-1 injections are the right treatment for you, we recommend consulting one of our knowledgeable doctors